Erica Scalambrino

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Patient Reported

Decision Making

Top Venues

International journal of laboratory hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Flora Peyvandi
D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation. Blood advances 8 (14) (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances 8 (11) (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances 8 (11) (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances 8 (11) (2024)
Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Flora Peyvandi
D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation. Blood advances 8 (14) (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances (2024)
Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Flora Peyvandi
D-dimer for patients on VKA vs DOAC. Impact on the validity of D-dimer to make decision for extended anticoagulation. Blood advances (2024)
Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Flora Peyvandi
D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation. Blood advances 8 (14) (2024)
Sara Arcudi, Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, Shermarke Hassan, Valentina Begnozzi, Elena Anna Boccalandro, Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi
Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis. Blood advances 8 (11) (2024)
Armando Tripodi, Erica Scalambrino, Marigrazia Clerici, Flora Peyvandi
Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients. Biomedicines 11 (6) (2023)
Armando Tripodi, Erica Scalambrino, Marigrazia Clerici, Flora Peyvandi
Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients. Biomedicines 11 (6) (2023)
Erica Scalambrino, Marigrazia Clerici, Flora Peyvandi, Armando Tripodi
Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection in plasma containing argatroban. International journal of laboratory hematology 44 (5) (2022)
Erica Scalambrino, Lidia Padovan, Veena Chantarangkul, Marigrazia Clerici, Andrea Artoni, Flora Peyvandi, Armando Tripodi
Responsiveness of the activated partial thromboplastin time and dilute thrombin time to argatroban: Results of an in vitro study. International journal of laboratory hematology 42 (3) (2020)